Louis Cappelli

Nov 12, 2024 | survivornet.com | Louis Cappelli

Gliomas are challenging to treat due to their infiltrative nature, which makes complete removal (with surgery) difficult. Surgery aims to remove as much of the tumor as possible without causing the patient harm, but it often leaves behind microscopic cells, which may lead to recurrence. Radiation therapy helps target remaining cancer cells after surgery and can be especially beneficial for tumors in hard-to-reach areas.

Oct 19, 2024 | survivornet.com | Louis Cappelli

Gliomas are the most common type of primary brain tumor in adults and often present complex challenges in treatment. The care pathway for glioma patients involves multiple steps and specialties to ensure the most effective treatment plan. Dr. Henry Friedman, Deputy Director of the Preston Robert Tisch Brain Tumor Center at Duke, explains how glioma treatment typically unfolds and the critical decisions that guide it.

Oct 19, 2024 | survivornet.com | Louis Cappelli

Gliomas are the most common type of brain tumor in adults and often carry specific genetic mutations that play a role in how the tumor grows and spreads. One of the most important mutations found in gliomas is in the IDH (isocitrate dehydrogenase) gene. Fortunately, new treatments have emerged to allow doctors to target this specific mutation and provide better outcomes for patients.

Oct 19, 2024 | survivornet.com | Louis Cappelli

Gliomas are the most common type of primary brain cancer in adults. Many gliomas, especially low- and early-grade gliomas, possess a genetic change called an IDH mutation. Recently, the FDA approved a drug called Vorasidenib, which targets this mutation to improve treatment outcomes for patients with IDH mutant gliomas. Read More Glioma Overview Gliomas can be divided into two types: IDH wild-type and IDH mutant gliomas.

Oct 18, 2024 | survivornet.com | Louis Cappelli

Gliomas are the most common primary malignant or cancerous brain tumors in adults. They originate cells from glial cells, which act to support the brain’s nerve cells. Scientists have discovered that certain changes in the DNA of cells, known as mutations, like the IDH mutation, can act as fuel, helping these tumors grow and spread. Recently, scientists have developed drugs to target this gene mutation, which can lead to better outcomes for patients and a new way to treat this disease.